A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Dettagli Bibliografici
Autore principale:	Islam, Saidul
Altri autori:	Sharmin, Shahana
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2022
Soggetti:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Accesso online:	http://hdl.handle.net/10361/17308

Documenti analoghi

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
di: Karim, Azrin
Pubblicazione: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
di: Meem, Manila
Pubblicazione: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
di: Alam, Tahera
Pubblicazione: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
di: Jahan, Nusrat
Pubblicazione: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
di: Ahmed, Nafisa
Pubblicazione: (2023)

Immunotherapy in the Management of Lung Cancer
di: Tasnim, Humayra
Pubblicazione: (2022)

A review on triple-negative breast cancer and its potential treatment
di: Niasa, Jannatul Ferdous
Pubblicazione: (2023)

Stem cells as therapeutic carrier in cancer treatment
di: Anika, Mysha Yeasmin
Pubblicazione: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
di: Hasan, Amit
Pubblicazione: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
di: Chakraborty, Anuradha
Pubblicazione: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
di: Khan, Muidul Hasan
Pubblicazione: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
di: Roy, Hredita
Pubblicazione: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
di: Emon, Kamrul Hasan
Pubblicazione: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
di: Mirza, Maisa Tasnim
Pubblicazione: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
di: Khan, Rezia Nowrin
Pubblicazione: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
di: Nuha, Nabiha Tahsin
Pubblicazione: (2024)

Role of statins as antagonists of SPARC in gastric cancer
di: Shahmat, Rad
Pubblicazione: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
di: Sorno, Rubina Haque
Pubblicazione: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
di: Ratu, Tabassum
Pubblicazione: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
di: Choki, Kinley
Pubblicazione: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
di: Razna, Amrin Islam
Pubblicazione: (2019)

A comprehensive review on drug repurposing in cancer treatment
di: Sarkar, Onusree
Pubblicazione: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
di: Mahaleka, Aarshi
Pubblicazione: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
di: Shaikat, Mahdi Mubin
Pubblicazione: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
di: Hasan, Sakib
Pubblicazione: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
di: Nawar, Anika
Pubblicazione: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
di: Deeba, Maliha Tasnim
Pubblicazione: (2018)

Targeting BRAFV600E in the treatment of CRC
di: Roja, Mashwiyat Samrin
Pubblicazione: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
di: Alam, Kazi Tasnuva
Pubblicazione: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
di: Rahman, Sanjida
Pubblicazione: (2024)

Biosimilar in lymphoma treatment
di: Tanisha, Mehrin Haque
Pubblicazione: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
di: Khondokar, Faiza
Pubblicazione: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
di: Islam, Nahidul
Pubblicazione: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
di: Beruni, Sajid Mahmud Al
Pubblicazione: (2022)

Oncogenes: new targets in cancer treatment
di: Chowdhury, Waseka Shams
Pubblicazione: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
di: Muntaha, Habibatul
Pubblicazione: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
di: Haque, Mushfiqul
Pubblicazione: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Karim, Samia Binte
Pubblicazione: (2024)